Clinical Trial Update: Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir [Phase 2]

View source ↗

Summary

Phase 2 trial update for lonafarnib with ritonavir in chronic hepatitis D completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Lonafarnib (lonafarnib)
• Ritonavir (Ritonavir)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis D | Phase 2 | Status: COMPLETED | Results posted: 2018-05-24